ArticleNeoplasia (New York, N.Y.)2012

The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.

Yaqiong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.